Specific response of mesenchymal tissue to cancerigenesis by cadmium.
D000818:Animals; D002104:Cadmium / Q000008:administration & dosage / Q000009:adverse effects*; D002273:Carcinogens / Q000009:adverse effects*; D003035:Cobalt / Q000009:adverse effects; D004475:Ectoderm / Q000187:drug effects; D004707:Endoderm / Q000187:drug effects; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D008297:Male; D008648:Mesoderm / Q000187:drug effects; D010521:Periosteum / Q000187:drug effects; D051381:Rats; D012513:Sarcoma, Experimental / Q000139:chemically induced; D015032:Zinc / Q000009:adverse effects
D002273:Carcinogens; D002104:Cadmium; D003035:Cobalt; D015032:Zinc